{
    "medicine_id": "e2609b0826dc4e6e6c4e2f85892927c82c526280",
    "platform_id": "DB05511",
    "metadata": {
        "name": "Adult Formula 50 60 61 v v Solution",
        "composition": "60 61 v v Piclidenoson",
        "clinical_particulars": {
            "therapeutic_indications": "Investigated for use treatment in cancer tumors unspecified eye disorders infections psoriasis and psoriatic disorders and rheumatoid arthritis Can Fite BioPharma has reported that by targeting the adenosine A3 receptor CF101 may also be used to treat Crohn s disease a serious gastrointestinal disorder",
            "contraindications": {
                "disease": "NA",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "CF 101 is an adenoside A3 agonist for the treatment of a variety of autoimmune inflammatory disorders particularly rhematoid arthritis In clinical trials it was found to be safe well tolerated and showed strong evidence of an anti inflammatory effect in rheumatoid arthritis patients In this trial a statistically significant correlation was found between A 3 AR expression level and response to the drug so A 3 AR expression may serve as a biopredictor of patient response",
                "excipients": "NA",
                "incompatibilities": []
            }
        },
        "revision_date": "2023-05-14"
    }
}